|
51 |
Adverse Effects Associated with Non-opioid and Opioid Treatment in Patients with Chronic Pain
Enthalten in Clinical drug investigation Bd. 32, 7.2.2013, Nr. 1, date:2.2012: 53-63
|
|
|
|
52 |
Adverse Effects of Immunosuppression in Pediatric Solid Organ Transplantation
Enthalten in Pediatric drugs Bd. 12, 22.8.2012, Nr. 1, date:2.2010: 35-49
|
|
|
|
53 |
A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®]
Enthalten in Drugs Bd. 72, 6.1.2012, Nr. 11, date:7.2012: 1543-1557
|
|
|
|
54 |
Aliskiren
Enthalten in Drugs Bd. 70, 18.9.2012, Nr. 15, date:10.2010: 2011-2049
|
|
|
|
55 |
Alogliptin
Enthalten in Drugs Bd. 70, 18.9.2012, Nr. 15, date:10.2010: 2051-2072
|
|
|
|
56 |
Amphotericin B Lipid Complex in the Management of Invasive Fungal Infections in Immunocompromised Patients
Enthalten in Clinical drug investigation Bd. 31, 28.8.2012, Nr. 11, date:11.2011: 745-758
|
|
|
|
57 |
Amyotrophic Lateral Sclerosis
Enthalten in CNS drugs Bd. 25, 29.8.2012, Nr. 1, date:1.2011: 1-15
|
|
|
|
58 |
An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions
Enthalten in PharmacoEconomics Bd. 28, 18.10.2012, Nr. 11, date:11.2010: 987-993
|
|
|
|
59 |
An Analysis of the Management of Cardiovascular Risk Factors in Routine Clinical Practice in Italy
Enthalten in High blood pressure & cardiovascular prevention Bd. 18, 27.11.2012, Nr. 1, date:3.2011: 19-30
|
|
|
|
60 |
An Economic Evaluation of Docetaxel and Paclitaxel Regimens in Metastatic Breast Cancer in the UK
Enthalten in PharmacoEconomics Bd. 27, 17.9.2012, Nr. 10, date:10.2009: 847-859
|
|
Administration
